Insider Transactions in Q2 2025 at Bright Health Group Inc. (BHG)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 13
2025
|
Jeffrey R Immelt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+30.51%
|
-
|
|
May 13
2025
|
Manuel Kadre Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+26.04%
|
-
|
|
May 13
2025
|
Kedrick D Adkins Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+38.97%
|
-
|
|
May 13
2025
|
Linda R Gooden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+38.97%
|
-
|
|
May 13
2025
|
Robert J Sheehy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+40.77%
|
-
|
|
May 13
2025
|
Matthew G Manders Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+38.54%
|
-
|
|
May 13
2025
|
Stephen Kraus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+38.97%
|
-
|
|
May 13
2025
|
Mohamad Makhzoumi |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+38.97%
|
-
|
|
May 13
2025
|
Andrew M Slavitt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+36.17%
|
-
|
|
May 12
2025
|
Jay Matushak Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
472
-1.15%
|
$2,832
$6.76 P/Share
|
|
May 12
2025
|
Jeffrey J Scherman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
112
-0.89%
|
$672
$6.76 P/Share
|
|
May 09
2025
|
Jay Matushak Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
978
+2.33%
|
-
|
|
May 09
2025
|
Jeffrey J Scherman Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
341
+2.64%
|
-
|